Back to top

Image: Bigstock

Five Reasons to Buy AMD (AMD) Ahead of Earnings

Read MoreHide Full Article

On Tuesday, January 30th, Advanced Micro Devices (AMD - Free Report) will release its fourth quarter earnings results after the bell. The company is a Zacks Rank 3 (Hold), and have a Value, Growth, and Momentum score of C.

Dave will look at AMD’s past earnings, take a look at what is currently going on with the company, and give us his thoughts on their upcoming earnings announcement.

Furthermore, Dave will uncover some potential options trades for investors looking to make a play on AMD ahead of earnings.

AMD in Focus

Advanced Micro Devices, Inc. is a world-class company with the innovation, execution, and vision to grow our leadership position in the industry. Today's world-class companies share three essential characteristics. First, they deliver innovative products and technologies that customers want. Second, they have established a proven track record of fast, efficient manufacturing execution. And third, they have a bold vision of where to take their business, and often their industry. Over the course of AMD's three decades in business, silicon and software have become the steel and plastic of the worldwide digital economy. Technology companies have become global pacesetters, making technical advances at a prodigious rate always driving the industry to deliver more and more, faster and faster. AMD's dedication to customer-centric innovation and competitive spirit is an unbroken thread running from our early days in the integrated circuit business, through an ever-broadening product portfolio.

AMD is expected to report earnings at $0.05 per share according to the Zacks Consensus Estimate. Last quarter they beat earnings expectations by 25%. They reported earnings at $0.10per share, beating their estimate of $0.08. They have an average earnings surprise of 31.67% over the last 4 quarters.

How should investors play AMD ahead of their earnings report? For insights on the best options trades, then tune in at 11:00am CST tomorrow to see David’s thoughts.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
 


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Advanced Micro Devices, Inc. (AMD) - free report >>